Metabolic and weight management peptides are a class of bioactive peptides that play significant roles in regulating metabolism, appetite, and body weight. These peptides are of great interest in research and clinical settings due to their potential to address obesity, diabetes, and other metabolic disorders. They work through various mechanisms, including influencing hormone levels, modulating energy expenditure, and altering nutrient absorption and storage.
AOD-9604: A modified form of human growth hormone, AOD-9604 is studied for its ability to promote fat loss without affecting muscle mass or appetite. It works by mimicking the fat-burning effects of growth hormone.
Melanotan II: Originally developed as a tanning agent, Melanotan II has shown potential in reducing appetite and promoting weight loss by activating melanocortin receptors involved in energy homeostasis.
5-Amino-1MQ: A small molecule that inhibits NNMT (Nicotinamide N-methyltransferase), an enzyme linked to obesity and type 2 diabetes. By reducing NNMT activity, 5-Amino-1MQ has been shown to enhance energy expenditure and reduce fat accumulation.
GLP-1 (Glucagon-Like Peptide-1): A hormone that increases insulin secretion and inhibits glucagon release, GLP-1 also slows gastric emptying and reduces appetite. Synthetic analogs of GLP-1, such as liraglutide and semaglutide, are used clinically to manage type 2 diabetes and promote weight loss.
Leptin: A hormone that regulates energy balance by inhibiting hunger. Synthetic leptin or leptin analogs are studied for their potential to treat obesity, particularly in individuals with leptin deficiency or resistance.
ARTICLES
EXERCISES
COMMUNITY
